Comparing NGS and NanoString platforms in peripheral blood mononuclear cell transcriptome profiling for advanced heart failure biomarker development

In preparation to create a clinical assay that predicts 1-year survival status of advanced heart failure (AdHF) patients before surgical/interventional therapies and to select the appropriate clinical assay platform for the future assay, we compared the properties of next generation sequencing (NGS)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Biol Methods
Päätekijät: Bondar, Galyna, Xu, Wenjie, Elashoff, David, Li, Xinmin, Faure-Kumar, Emmanuelle, Bao, Tra-Mi, Grogan, Tristan, Moose, Jim, Deng, Mario C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Journal of Biological Methods 2020
Aiheet:
Benchmark
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6974694/
https://ncbi.nlm.nih.gov/pubmed/31976350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14440/jbm.2020.300
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia